Company intelligence / Profile preview

Jova Care

Ownership: Private
Development stage: Commercial

Overview

Javara provides integrated clinical research services at the point of care, embedding staff and infrastructure into healthcare organizations to increase patient participation in clinical trials.

Industry: Contract Research Organization

Drug pipeline

1 asset

zanubrutinib

Commercial

Indications: Chronic lymphocytic leukemia, Mantle cell lymphoma, Marginal zone lymphoma, Waldenström's macroglobulinemia

Partnerships

Healthcare organizationsBiopharma companiesBiotech companiesCROs

Beyond the preview

Go deeper on Jova Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jova Care.

Explore the full profile